Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today

Avicanna reported annual revenue of CA$25.5 million ($18.38 million) for the year ended December 31, 2024, up 52% compared to 2023. Fourth-quarter revenue totaled CA$6.6 million. Gross profits climbed …